Traumatic Brain Injury(TBI) - Pipeline Insights, 2017

Publisher Name :
Date: 05-Jul-2017
No. of pages: 156
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Traumatic Brain Injury-Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this indication. Key objective of the report is to establish the understanding for all the pipeline drugs that fall under Traumatic Brain Injury. This report provides information on the therapeutic development based on the Traumatic Brain Injury dealing with all the pipeline drugs, comparative analysis of Traumatic Brain Injury at various stages covering Phase III, Phase II, Phase I, IND, Pre-clinical, and Discovery stages therapeutics assessment by monotherapy products and molecule type drug information. The report also covers the company's information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight's team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Traumatic Brain Injury(TBI) - Pipeline Insights, 2017

Table of Contents

Introduction
Overview
Pipeline Therapeutics
Therapeutics under Development by Companies
Late Stage Products (Phase III)
Mid Stage Products (Phase II)
Early Stage Products (Phase I and IND)
Pre-clinical and Discovery Products
Therapeutic Assessment: Active Products
Dormant Products
Discontinued Products
Comparative Analysis
Companies involved in Therapeutic Development
Appendix
Consulting Services
About DelveInsight
Contact Us
Disclaimer

List of Tables

Table 1: Number of Products Under Development for Traumatic Brain Injury
Table 2: Number of Products under Development by Companies
Table 3: Late Stage Products (Phase III)
Table 4: Mid Stage Products (Phase II)
Table 5: Early Stage Products (Phase I and IND)
Table 6: Pre-clinical Products
Table 7: Discovery Products
Table 8: Assessment by Monotherapy Products
Table 9: Assessment by Combination Therapy Products
Table 10: Assessment by Route Of Administration
Table 11:Assessment by Stage and Route Of Administration
Table 12: Assessment by Molecule Type
Table 13: Assessment by Stage and Molecule Type
Table 14: Dormant Products
Table 15: Discontinued Products
Table 16: American Life Science Pharmaceuticals (ALSP), Overview
Table 17: Anvyl LLC, Overview
Table 18: Apollo Endosurgery, Overview
Table 19: Aptinyx, Overview
Table 20: Astrocyte Pharmaceuticals Inc., Overview
Table 21: Athersys, Overview
Table Continued…
Table 56: VG Life Sciences, Overview

List of Figures

Figure 1: Symptoms of Traumatic Brain Injury
Figure 2:Number of Products under Development for Traumatic Brain Injury,2017
Figure 3: Late Stage Products (Phase III)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Early Stage Products (Phase I and IND)
Figure 6: Pre-clinical and Discovery Products
Figure 7: Assessment by Monotherapy Products
Figure 8: Assessment by Combination Therapy Products
Figure 9: Assessment by Route of Administration
Figure 10: Assessment by Stage and Route of Administration
Figure 11: Assessment by Molecule Type
Figure 12: Assessment by Stage and Molecule Type
Figure 13: Dormant Products
Figure 14: Discontinued Products
  • United States Gabapentin Market Report 2017
    Published: 17-Aug-2017        Price: US 3800 Onwards        Pages: 98
    In this report, the United States Gabapentin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Gabap......
  • Encephalomyelitis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 62
    Encephalomyelitis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalomyelitis - Pipeline Review, H2 2017, provides an overview of the Encephalomyelitis (Central Nervous System) pipeline landscape. Encephalomyelitis is an inflammation of the brain and spinal cord. Encephalomyelitis can be caused by a variety of conditions that lead to irritation of the brain and spinal cord. Amo......
  • Epilepsy - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 420
    Epilepsy - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and sho......
  • Nicotine Addiction - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 63
    Nicotine Addiction - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction - Pipeline Review, H2 2017, provides an overview of the Nicotine Addiction (Central Nervous System) pipeline landscape. Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine. Predisposing factors include age, depression, schizophrenia, post......
  • Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 163
    Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2017, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline landscape. Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that includ......
  • Global Epilepsy Therapeutics Market Research Report 2017
    Published: 16-Aug-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Epilepsy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Epilepsy Therapeutics in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global Gabapentin Sales Market Report 2017
    Published: 11-Aug-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the global Gabapentin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units) , revenue (Million USD) , market share and growth rate of Gabapentin for these regions, from 2012 to 2022 (forecast) , covering - United States - China - Europe - Japan - So......
  • Global Gabapentin Market Research Report 2017
    Published: 07-Aug-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Gabapentin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gabapentin in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • Spasticity - Epidemiology Insights to 2025
    Published: 28-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Spasticity -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Spasticity in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Spasticity. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Spasticity. The report contains the targeted patient populations and the forecast method......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs